Literature DB >> 34626980

A biodegradable "Nano-donut" for magnetic resonance imaging and enhanced chemo/photothermal/chemodynamic therapy through responsive catalysis in tumor microenvironment.

Shaoqi Guan1, Xijian Liu2, Yang Fu3, Chunlin Li4, Jinxia Wang1, Qixiang Mei3, Guoying Deng4, Wenrui Zheng1, Zhiping Wan5, Jie Lu1.   

Abstract

Prussian blue (PB) is a safe photothermal agent for tumor therapy, yet poor photothermal effect and single therapeutic function severely restrict its further clinical applications. Herein, a biodegradable "Nano-donut" (CMPB-MoS2-PEG) is fabricated for magnetic resonance (MR) imaging and enhanced photothermal therapy (PTT)/ chemodynamic therapy (CDT)/chemotherapy through responsive catalysis in tumor microenvironment (TME). The "Nano-donut" is organically composed of Cu/Mn ions doped-PB and MoS2. The porous donut structure of CMPB-MoS2-PEG endows them as a carrier for delivery of doxorubicin hydrochloride (DOX) to tumor site. The framework of Nano-donut specifically decomposes in TME due to the reaction between Fe2+/Fe3+ and H2O2. The multivalent elements (Cu/Fe/Mn ions) decrease the bandgap and then enhance CDT by synergistically catalyzing H2O2 into toxic ·OH. Meanwhile, the Mn4+ also reacts with H2O2 to generate O2, improving the hypoxia of TME and enhancing the chemotherapy effect of released DOX. The MoS2 mingles in the PB, which significantly enhances photothermal conversion efficiency (η) effect of PB from 16.02% to 38.0%. In addition, Fe3+ as T2-weighted MR imaging agent can achieve MR imaging-guided therapy. The data clearly shows Nano-donut/DOX nanocomposites (NCs) have a remarkable inhibition for cancer cells and excellent biological safety in tumor treatment.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CMPB-MoS(2)-PEG; Chemodynamic therapy; Chemotherapy; Photothermal therapy; Prussian blue; Responsive catalysis

Mesh:

Substances:

Year:  2021        PMID: 34626980     DOI: 10.1016/j.jcis.2021.09.186

Source DB:  PubMed          Journal:  J Colloid Interface Sci        ISSN: 0021-9797            Impact factor:   8.128


  5 in total

Review 1.  Nanoparticles as Physically- and Biochemically-Tuned Drug Formulations for Cancers Therapy.

Authors:  Valentina Foglizzo; Serena Marchiò
Journal:  Cancers (Basel)       Date:  2022-05-17       Impact factor: 6.575

Review 2.  Manganese-based hollow nanoplatforms for MR imaging-guided cancer therapies.

Authors:  Shuang Liang; Guangfu Liao; Wenzhen Zhu; Li Zhang
Journal:  Biomater Res       Date:  2022-07-06

3.  Manganese-Based Prussian Blue Nanocatalysts Suppress Non-Small Cell Lung Cancer Growth and Metastasis via Photothermal and Chemodynamic Therapy.

Authors:  Danruo Fang; Zeyu Liu; Hansong Jin; Xiulin Huang; Yongxin Shi; Suqin Ben
Journal:  Front Bioeng Biotechnol       Date:  2022-06-22

Review 4.  Recent Advances in Transition-Metal Based Nanomaterials for Noninvasive Oncology Thermal Ablation and Imaging Diagnosis.

Authors:  Qiuxia Peng; Zhangbo Qian; Huali Gao; Kun Zhang
Journal:  Front Chem       Date:  2022-04-14       Impact factor: 5.545

5.  PPy@Fe3O4 nanoparticles inhibit the proliferation and metastasis of CRC via suppressing the NF-κB signaling pathway and promoting ferroptosis.

Authors:  Zhilong Yu; Shanshi Tong; Chenyi Wang; Zizhen Wu; Yingjiang Ye; Shan Wang; Kewei Jiang
Journal:  Front Bioeng Biotechnol       Date:  2022-09-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.